(Q45905161)

17 December 2017

title

Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study. (English)

1 reference

17 December 2017

3

Norikazu Masuda

1 reference

17 December 2017

author name string

Akemi Kataoka

1

1 reference

17 December 2017

Eriko Tokunaga

2

1 reference

17 December 2017

Tadahiko Shien

4

1 reference

17 December 2017

Kimiko Kawabata

5

1 reference

17 December 2017

Mika Miyashita

6

1 reference

17 December 2017

publication date

16 April 2013

1 reference

17 December 2017

published in

Breast Cancer

1 reference

17 December 2017

volume

21

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

643-650

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s12282-013-0466-2

exact match

0 references

cites work

Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Women age < or = 35 years with primary breast carcinoma: disease features at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Biological characteristics and medical treatment of breast cancer in young women-a featured population: results from the NORA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Is breast cancer the same disease in Asian and Western countries?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001--an institutional review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Receipt of locoregional therapy among young women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0466-2

10.1007/S12282-013-0466-2

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017